Lapachone actually dicreses NAD+ and cause NAD+ exhaustion in the paper I posted earlier.
It is not specific to cancer cells. It is specific to NQO1.
Sorry 'Mike DC" but you are a troll... and a bad one. What you write here is just a way to mislead people knowing you didnd read anything about the topic and you oblige us to correct your fake bold statement.
I explained you already to get back and see studies in this thread but you prefer to continue to troll and post non sense "it is cytotoxic in all cells because they tested in cancer cell line in this study, and not in normal cell line, so it means its toxic". How on earth its possible to make such statement ?
And guess what, there is studies that tested this:
https://www.ncbi.nlm...pubmed/12598645 :" Selective killing of cancer cells by beta -lapachone: direct checkpoint activation as a strategy against cancer.
Most chemotherapeutic drugs kill cancer cells by indirectly activating checkpoint-mediated apoptosis after creating nonselective damage to DNA or microtubules, which accounts for their toxicity toward normal cells. We seek to target cancer cells by directly activating checkpoint regulators without creating such damage. Here, we show that beta-lapachone selectively induces apoptosis in cancer cells without causing the death of nontransformed cells in culture. This unusual selectivity against cancer cells is preceded by activation of S-phase checkpoint and selective induction of E2F1, a regulator of checkpoint-mediated apoptosis. This study suggests direct checkpoint activation as a strategy against cancer."
impressive isnt ? Actually not and :
beta lapachone activate NQO1 and increase NAD+ and increased lifespan in mice https://www.ncbi.nlm...les/PMC3469505/
also similar result here: http://www.nature.co...otcallback=true
and read first page